PRP for Sexual Health in Men: The P-Shot Deep Dive

The first time a patient asks about the P-Shot in clinic, his eyes usually flick toward the door before he says the word. Not because he's embarrassed, exactly. More because he's been reading message boards at 1am and he can't tell what's medicine, what's marketing, and what's somewhere in between. I get it. The P-Shot (short for Priapus Shot, a trademarked name for an intracavernosal platelet-rich plasma injection) has been promoted hard for a decade now, and the gap between the hype and the data is wider than most clinics will admit.

I'm Dr. Farhan Abdullah, an internal medicine physician and the medical director at Magnolia Functional Wellness in Southlake. I see men every week who've tried Viagra or Cialis, who've maybe done a course of low-intensity shockwave, and who are wondering whether PRP injections are worth it. So let's walk through what the P-Shot actually is, what the evidence really says in 2026, who tends to benefit, who doesn't, and how to think about it without falling into either the "miracle cure" or "snake oil" camp.

By Dr. Farhan Abdullah, DO | Medical Director, Magnolia Functional Wellness | Southlake, TX

What the P-Shot Actually Is (and Isn't)

Let's start with the mechanics. We draw a small tube of your blood, usually around 30 to 60 mL. That blood gets spun in a centrifuge to separate the platelets from the red and white cells. Platelets are tiny cell fragments that everybody knows for clotting, but they also carry a payload of growth factors: PDGF, TGF-beta, VEGF, EGF, and a handful of others that play roles in tissue repair, angiogenesis (new blood vessel growth), and nerve regeneration.

After the spin, we end up with a concentrated layer of platelets in plasma. That's PRP. With the P-Shot, we then inject that PRP directly into the corpora cavernosa, the two spongy chambers of erectile tissue inside the penis. A small amount typically goes into the glans as well. We use a fine needle, a topical numbing cream, and sometimes a penile block for comfort. Most men describe the procedure as uncomfortable but not painful.

Here's what it's not. It's not stem cell therapy. It's not exosome therapy. It's not a magic shot that adds inches (despite what some clinics' websites still imply). It's an autologous biologic injection meant to stimulate microvascular and nerve repair in tissue that's been damaged by diabetes, vascular disease, prior surgery, or just decades of normal wear and tear.

One detail that often gets lost in marketing material: PRP preparations vary wildly from clinic to clinic. Platelet concentration, leukocyte content, activation method, injection volume, number of sessions, all of it. A 2026 narrative review in the Journal of Clinical Medicine by Qu and colleagues at Sichuan University pointed out exactly this problem and proposed a minimum reporting checklist for PRP urology studies. When you compare a study where the PRP had a 5x baseline platelet concentration to one with a 2x concentration, you're not really comparing the same intervention. That matters when you're trying to make sense of conflicting trial results.

What the 2026 Evidence Actually Shows

This is where I have to be honest with patients, even when it's not the answer they want. The most rigorous data we have on PRP for erectile dysfunction comes from randomized controlled trials, and the picture is mixed.

In January 2026, Jacob and colleagues from the Manchester Andrology Research Collaborative published a meta-analysis in the Journal of Sexual Medicine pooling seven RCTs with 512 total participants. They looked at standardized changes in IIEF (International Index of Erectile Function) scores at 1, 3, and 6 months after intracavernosal PRP injection compared to placebo. The pooled standardized mean differences favored PRP slightly but the confidence intervals crossed zero at 1 month and 6 months, with statistical significance at 3 months. Heterogeneity between studies was high (I² of 74 to 83 percent), and the authors' conclusion was that current evidence does not support a consistent, clinically meaningful improvement in erectile function with PRP monotherapy compared with placebo.

That's not the conclusion most clinic websites lead with. But it's what the highest-quality synthesis of the data currently says.

So why am I still offering it in my practice? A few reasons. First, the meta-analysis explicitly excluded studies combining PRP with other regenerative therapies, and in clinical practice most of us are stacking modalities (more on that below). Second, the safety profile is excellent. Only mild adverse events like small hematomas or local plaque formation were reported across all trials. Third, the same review notes a real placebo effect of intracavernosal injection itself, which is interesting on its own. And fourth, the subset of patients who do respond often respond meaningfully.

A 2025 review by Mikkel Fode in the Danish Medical Journal looking at the broader category of regenerative therapies (PRP, stem cells, and low-intensity shockwave) for ED reached a similar nuanced conclusion. The biology is plausible. The preliminary data is encouraging in subgroups. But standardized research with longer follow-up is still needed to establish clear clinical efficacy.

What I tell my patients is this: the P-Shot is investigational, biologically reasonable, and generally safe. It's not a guaranteed fix. If anyone tells you otherwise, they're either uninformed or selling something.

Who Tends to Benefit (and Who Probably Won't)

After thousands of hours of running men's health protocols, I've developed a pretty clear sense of who lights up on PRP and who doesn't.

Men who tend to do well: those with mild to moderate vasculogenic ED, men who get some response to PDE5 inhibitors but want to reduce their dependence on them, post-prostatectomy patients in the rehabilitation phase, men with early Peyronie's disease, and patients with mild ED tied to diabetes or metabolic syndrome who've gotten their underlying health in order. Younger men with psychogenic or stress-related ED sometimes respond, though the mechanism there is murkier.

Men who tend not to benefit much: severe end-stage vasculogenic ED with documented arterial insufficiency on Doppler, men with significant venous leak, longstanding diabetic neuropathy that's already destroyed nerve architecture, and patients with anatomical issues that PRP simply can't fix. If someone comes in with rock-bottom morning erections, no response to 100mg of sildenafil, and a 25-year history of poorly controlled diabetes, I'm having a different conversation. We talk about optimizing his PDE5 inhibitor regimen, maximizing his hormones, sometimes referring out to urology for surgical options.

The biggest variable, in my experience, isn't PRP technique. It's the foundation underneath. A man with low testosterone, untreated sleep apnea, a hemoglobin A1c of 8.4, and a sedentary lifestyle is not going to get the same response as the same guy after we've optimized his hormones, treated his apnea, dropped his A1c to 5.8, and gotten him moving four days a week. Erectile function is a barometer for cardiovascular and metabolic health. PRP is a tool, not a substitute for fixing what's broken upstream.

Why We Often Combine PRP With Other Modalities

This is where the conversation gets more nuanced and, honestly, where the published RCT data falls short of representing what happens in good clinics. The trials evaluate PRP monotherapy. Real practice typically stacks.

The most common combination I run is low-intensity shockwave therapy (we use SoftWave) layered with PRP. Shockwave works through mechanotransduction. Acoustic waves create microtrauma that triggers the body to release endogenous growth factors, recruit stem cells, and stimulate angiogenesis. PRP delivers a bolus of exogenous growth factors directly into the same tissue. The theoretical synergy is that shockwave wakes the tissue up and recruits the cellular machinery, and PRP feeds that machinery.

For Peyronie's disease, the combination story is similar. Intralesional PRP targeted at the plaque, often combined with traction therapy and sometimes oral pentoxifylline or topical verapamil, is more effective than any single piece of that combo alone, at least in my hands. If you want a more procedural breakdown specific to the men's protocol we run, our P-Shot service page covers the structured course we use at the clinic.

For men who fit the profile, I'll also pair the P-Shot with testosterone optimization if his free and total levels warrant it, peptide therapy in select cases (PT-141 is a different mechanism but pairs nicely for libido), and aggressive metabolic work (often a GLP-1 if there's metabolic syndrome, plus the standard lifestyle scaffolding).

Is this evidence-based? Partially. The individual components have varying levels of support. The combinations are less studied because RCTs are expensive and combination trials are even more expensive. But this is where good clinical judgment fills the gap between what's been studied and what makes physiological sense.

What the Procedure Day Looks Like

For anyone considering it, here's the practical reality. You arrive, we draw your blood. The centrifuge spin takes about 15 minutes. While that's running, we apply a topical anesthetic to the injection sites and let it sit. When the PRP is ready, we do a brief penile block with lidocaine for comfort. Then we inject the PRP into the corpora cavernosa and a small amount into the glans, using a very fine needle.

The whole appointment runs about 60 to 75 minutes. Most men feel some pressure and a brief sting during the injection but describe it as much less uncomfortable than they expected. Bruising can happen and usually resolves in a few days. You can drive home, go back to work, work out the next day. Sexual activity is fine after 48 hours, and we often recommend a vacuum erection device to help with tissue perfusion during the early healing window.

Most protocols involve a series of three sessions spaced four to six weeks apart, then a maintenance approach based on response. Results, when they come, typically build over three to six months as the tissue remodels. This isn't a same-day pop-a-pill experience. It's slower.

The Honest Cost-Benefit Conversation

The P-Shot isn't cheap, and it's not covered by insurance. A reasonable single-session price in DFW runs $1,200 to $1,800 depending on the clinic and what's included. A three-session course can run $3,000 to $5,000. Stacking with shockwave adds more.

So before anyone signs up, I want them to think through a few things. Have you actually optimized the cheap, evidence-based stuff first? PDE5 inhibitors are off-patent and inexpensive. Testosterone replacement, if your labs justify it, is comparatively affordable. Losing 20 pounds costs nothing but discipline. CPAP for undiagnosed sleep apnea is often life-changing. If you haven't run that play, doing PRP first is like installing a new turbocharger on an engine with bad spark plugs.

If you've done the foundational work and you still want to dial things in further, the P-Shot becomes a more rational add-on. It's reasonable, it's safe, and it works for a meaningful subset of men. Just don't expect it to do work it can't do.

Between Southlake Town Square parking lots and the slow crawl up the tollway, I see a lot of men in their 40s and 50s who quietly think their sex life is just supposed to fall apart. It isn't. There's a real toolkit available now that didn't exist 15 years ago. The P-Shot is one tool in that kit. Used in the right patient, alongside the right foundation and the right combination therapies, it can be a real piece of the puzzle. At Magnolia Functional Wellness in Southlake, we try to be straight with men about what each piece can and can't do, and we build the protocol around the person, not the procedure.